|
US2016377618A1
|
|
Pcsk9 quantification by immunodetection
|
|
US2016357935A1
|
|
Novel set of fasting blood biomarkers to detect patients with impaired glucose tolerance
|
|
US2016291018A1
|
|
Use of pcsk9 and ldl-r activity for treating cardiovascular risk
|
|
US2016356789A1
|
|
Method of Detection of Summed Cardiac Troponins for Cardiovascular Risk Stratification
|
|
WO2016118763A1
|
|
Lpl/rlp ratio for assessment of cardiovascular disease risk
|
|
WO2016069639A1
|
|
Lp(a) subform size identification by capillary isoteachophoresis electrophoresis with laser-induced-fluorescence
|
|
CA2933605A1
|
|
Lp(a) subform size identification using zonal gel immuno-fixation electrophoresis
|
|
CA2921205A1
|
|
Cylinder cam for gel electropheresis
|
|
US2016041123A1
|
|
Applicator comb for gel electrophoresis
|
|
US2014343268A1
|
|
Methods for purifying nucleic acids and devices thereof
|
|
US2014200177A1
|
|
Method of treating a patient determined to be at risk of developing occult pancreatic beta-cell dysfunction
|
